BioLargo, Inc.
BLGO
$0.13
-$0.01-5.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.29M | -2.95M | -6.48M | -1.19M | -1.16M |
| Total Depreciation and Amortization | 111.00K | 137.00K | 103.00K | 81.00K | 85.00K |
| Total Amortization of Deferred Charges | 62.00K | 90.00K | 39.00K | 39.00K | 28.00K |
| Total Other Non-Cash Items | -445.00K | 48.00K | 3.91M | -16.00K | -65.00K |
| Change in Net Operating Assets | -359.00K | 1.09M | -333.00K | -1.03M | -723.00K |
| Cash from Operations | -2.92M | -1.59M | -2.76M | -2.12M | -1.83M |
| Capital Expenditure | -32.00K | -13.00K | -33.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 289.00K | 192.00K | -- |
| Cash from Investing | -32.00K | -13.00K | 256.00K | 192.00K | -- |
| Total Debt Issued | 2.40M | -26.00K | 0.00 | 721.00K | 590.00K |
| Total Debt Repaid | -8.00K | 18.00K | -9.00K | -5.00K | -4.00K |
| Issuance of Common Stock | 803.00K | 960.00K | 1.43M | 2.10M | 295.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 2.15M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 15.00K | -15.00K |
| Cash from Financing | 3.19M | 952.00K | 3.57M | 2.83M | 866.00K |
| Foreign Exchange rate Adjustments | -2.00K | -12.00K | 8.00K | 0.00 | -20.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 239.00K | -663.00K | 1.08M | 907.00K | -984.00K |